| Date Filed | Type | Description |
| 02/20/2009 |
8-K
| Quarterly results |
| 02/10/2009 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/14/2008 |
10-Q
| Quarterly Report for the period ended June 30, 2008 |
| 08/08/2008 |
8-K/A
| Form 8-K/A -- Current report [amend] |
| 08/04/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/25/2008 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ... |
| 07/10/2008 |
4
| WOLFSTEIN PHILIP T (Director) has filed a Form 4 on CHAD THERAPEUTICS INC|
Txns:
| Disposed of 62,618 shares
@ $0.19, valued at
$11.9k
|
|
| 06/27/2008 |
10-K
| Annual Report for the period ended March 31, 2008 |
| 05/06/2008 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 05/06/2008 |
5
| MCCULLOH KEVIN (Sr. VP of Engineering) has filed a Form 5 on CHAD THERAPEUTICS INC |
| 05/06/2008 |
5
| Kern Tracy A (CFO) has filed a Form 5 on CHAD THERAPEUTICS INC |
| 05/06/2008 |
5
| JONES THOMAS E (Chairman) has filed a Form 5 on CHAD THERAPEUTICS INC |
| 05/06/2008 |
5
| DEL TORO ALFONSO (VP Manufacturing) has filed a Form 5 on CHAD THERAPEUTICS INC |
| 04/25/2008 |
4
| WOLFSTEIN PHILIP T (Director) has filed a Form 4 on CHAD THERAPEUTICS INC|
Txns:
| Granted 25,000 options to buy
@ $0.4, valued at
$10k
|
|
| 04/25/2008 |
4
| Griggs Kathleen (Director) has filed a Form 4 on CHAD THERAPEUTICS INC|
Txns:
| Granted 25,000 options to buy
@ $0.4, valued at
$10k
|
|
| 04/25/2008 |
4
| BROPHY JAMES M (Director) has filed a Form 4 on CHAD THERAPEUTICS INC|
Txns:
| Granted 25,000 options to buy
@ $0.4, valued at
$10k
|
|
| 04/25/2008 |
4
| WOLFSTEIN PHILIP T (Director) has filed a Form 4 on CHAD THERAPEUTICS INC|
Txns:
| Granted 25,000 options to buy
@ $0.4, valued at
$10k
|
|
| 03/11/2008 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi... |
| 02/27/2008 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers |
| 02/20/2008 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 02/14/2008 |
10-Q
| Quarterly Report for the period ended December 31, 2007 |
| 02/13/2008 |
SC 13G/A
| LAURUS MASTER FUND LTD reports a 10% stake in CHAD THERAPEUTICS, INC. |
| 02/01/2008 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/18/2008 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 01/04/2008 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 01/02/2008 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 12/28/2007 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 11/19/2007 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 11/19/2007 |
10-Q
| Quarterly Report for the period ended September 30, 2007 |
| 09/18/2007 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 09/14/2007 |
10-K/A
| Annual Report for the period ended March 31, 2007 [amend] |
| 08/14/2007 |
10-Q
| Quarterly Report for the period ended June 30, 2007 |
| 08/10/2007 |
SC 13G
| LAURUS MASTER FUND LTD reports a 10% stake in CHAD THERAPEUTICS, INC. |
| 08/03/2007 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
|